Researchers at the Center for Anxiety and Related Disorders at Boston University are conducting a study to evaluate the potential effects of 3 single doses of either an investigational medication or placebo, on the effectiveness of a particular form of psychotherapy (cognitive-behavioral therapy). The medication is investigational because it is not yet FDA approved. It is not designed to reduce anxiety symptoms on its own, but may improve the effectiveness of this type of therapy.
Participation involves the following:
Individuals who are eligible for the study will receive free cognitive therapy treatment as part of study participation.